EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 120 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,000 | 0.0% | 10 | -33.3% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 15 | -31.8% | 0.00% | -100.0% |
| Q3 2016 | $2,000 | +100.0% | 22 | -15.4% | 0.00% | – |
| Q2 2016 | $1,000 | -75.0% | 26 | -69.0% | 0.00% | -100.0% |
| Q1 2016 | $4,000 | -50.0% | 84 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $8,000 | +60.0% | 84 | +15.1% | 0.00% | 0.0% |
| Q3 2015 | $5,000 | 0.0% | 73 | +30.4% | 0.00% | +100.0% |
| Q2 2015 | $5,000 | -37.5% | 56 | -66.1% | 0.00% | -50.0% |
| Q1 2015 | $8,000 | – | 165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |